Last reviewed · How we verify
Secondary Prophylaxis — Competitive Intelligence Brief
phase 3
Infectious Diseases
Small molecule
Live · refreshed every 30 min
Target snapshot
Secondary Prophylaxis (Secondary Prophylaxis) — Children's Hospital Medical Center, Cincinnati. This drug is used to prevent the recurrence of certain infections.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Secondary Prophylaxis TARGET | Secondary Prophylaxis | Children's Hospital Medical Center, Cincinnati | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Secondary Prophylaxis CI watch — RSS
- Secondary Prophylaxis CI watch — Atom
- Secondary Prophylaxis CI watch — JSON
- Secondary Prophylaxis alone — RSS
Cite this brief
Drug Landscape (2026). Secondary Prophylaxis — Competitive Intelligence Brief. https://druglandscape.com/ci/secondary-prophylaxis. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab